BYSOS - India's formost Stock Fantasy Gaming Platform
28 subscribers
6.33K photos
4 videos
2 files
11.5K links
BYSOS, is the foremost stocks fantasy gaming platform. BYSOS is a platform where individuals can begin appreciating the fun and delight of fantasy gaming on stocks and can get familiar with stocks to upgrade their skills on sto
Download Telegram
Buy or sell? What should investors do with Tata Motors shares post Q1 results
Ahead of Q1FY24 earnings announcement today, shares of Tata Motors settled 1.62 per cent higher at ₹639.45 apiece, after hitting a 52-week high of ₹64...
Canara Bank, Sun TV, 3 others placed under F&O ban on NSE for July 26; check details
The derivative contracts in the mentioned securities have crossed 95 per cent of the market-wide position limit and have been currently put in the ban...
After a weak June quarter, recovery to be gradual for SRF
Since its financial results were announced, the stock fell 2%, contributing to cumulative decline of 5.5% so far in 2023.
Yatharth Hospital IPO opens today: 10 key things to know
Yatharth Hospital IPO opens on July 26. The company raised ₹206 crore from anchor investors. Price band set at ₹285 to ₹300 per share. IPO aims to rai...
Buy or sell: Vaishali Parekh recommends three stocks to buy today — 26th July
Markets ended flat after a recent dip, with selective participation from midcaps. Further consolidation is expected with high volatility due to monthl...
Global markets update: US stocks advance on upbeat earnings
S&P 500 rises 0.3%, Dow Jones Industrial Average gains 0.1%, Nasdaq composite climbs 0.6%
2 PSU Stocks You Could ‘Bank’ Upon
In the past few days, two PSU banks have reported strong operational performance. Find out more details inside.
ITC Share Price Falls as Investors Disappointed with Demerger Ratio
What will happen after ITC hives off ITC Hotels? Continue reading to know more about the ITC Hotels demerger, share split ratio, and more
Yatharth Hospital IPO opens: GMP, subscription status, should you subscribe or not?
Yatharth Hospital IPO opens for subscription, with a price band of ₹285 to ₹300 per share. The IPO has raised ₹205.96 crores from anchor investors. Th...
Bajaj Auto share price nears all-time high on strong Q1 results, should you buy, sell or hold?
Bajaj Auto's share price is near its all-time high of ₹4,995 after Q1FY24 numbers. However, brokerages have mixed views, with Nuvama equities retainin...
US Fed decision today: Will it be the last hike of the current cycle? How could it impact the Indian market?
The US Federal Reserve is expected to raise benchmark rates by 25 bps to the 5.25-5.50 per cent range on Wednesday. Investors will be watching for cue...
Yasons Chemex Care IPO: GMP, subscription status on day 3, and other key details
Yasons Chemex Care IPO subscribed 59.60 times on day 3. Retail investors subscribed 68.76 times, non-institutional buyers subscribed 47.71 times. GMP ...
Innovatus Entertainment IPO: GMP, subscription status on day 2, and other key details here
Innovatus Entertainment Networks IPO has set the price band at ₹50 per equity share and plans to raise funds for various purposes. The IPO was subscri...
FIIs pump₹922 crore in Indian stocks; DII invest₹470 crore on July 26; check details
As per the NSE data, FIIs cumulatively bought ₹8,700.87 crore of Indian equities, while they sold ₹7,778.03 crore --- resulting in an inflow of ₹922.8...
US Fed meet outcome: From rate hike to road ahead - Key takeaways from Fed decision
The quarter percentage-point hike, a unanimous decision, lifted the target range for the Fed’s benchmark federal funds rate to 5.25 per cent to 5.5 pe...
Delta Corp, Sun TV, RBL Bank placed under F&O ban on NSE for July 27; check details
The derivative contracts in the mentioned securities have crossed 95 per cent of the market-wide position limit and have been currently put in the ban...
Oil retreats from 3-month high peak ahead of US Fed outcome, lower US crude stock
Back home, on the Multi Commodity Exchange (MCX), crude oil futures due for a August 21 expiry, were last trading lower by 0.51 per cent at ₹6,496 per...
Cipla share price jumps over 8% after robust Q1 performance
Drug major Cipla posted a 45.1% rise in its consolidated net profit in Q1FY24 at ₹995.7 crore as compared to ₹696.4 crore in the corresponding quarter...